- Home
- DTF vs DXR Comparison
DTF vs DXR Comparison
Compare DTF & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTF | DXR |
|---|---|---|
| Founded | N/A | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.0M | 71.4M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DTF | DXR |
|---|---|---|
| Price | $11.48 | $9.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.6K | ★ 12.4K |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,446,345.00 |
| Revenue This Year | N/A | $44,935.22 |
| Revenue Next Year | N/A | $74.79 |
| P/E Ratio | ★ N/A | $33.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.05 | $7.10 |
| 52 Week High | $11.60 | $14.76 |
Technical Indicators
Market Signals| Indicator | DTF | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 54.05 | 37.48 |
| Support Level | $11.45 | $8.45 |
| Resistance Level | $11.59 | $9.88 |
| Average True Range (ATR) | 0.09 | 0.38 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 64.82 | 47.93 |
Price Performance
Historical ComparisonAbout DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.